Evrofarma S.A.: Company Profile and SWOT Analysis by ICDResearch

VIEWS: 3 PAGES: 31

More Info
									Evrofarma S.A.

_________________________________________________________________________________



Evrofarma S.A.                                                           Financial Snapshot

                                                                         Operating Performance
Fast Facts
                                     3rd Km Alexandroupolis-Airport,     The company reported revenue of US$38.13 million
Headquarters Address
                                     Alexandroupoli, 681 00,Greece       during the fiscal year 2010 (2010). The company's
                                                                         revenue grew at a CAGR of 5.59% during 2006–
Telephone                            + 30 2551 088120
                                                                         2010, with an annual decline of -4.07% over 2009. In
                                                                         2010, the company recorded an operating margin of
Fax                                  + 30 2551 088153                    7.15%, as against 6.45% in <2009.

Website                              www.evrofarma.gr
                                                                         Revenue and Margins
Ticker Symbol, Stock Exchange        EVROF, Athens Stock Exchange

Number of Employees                  149

Fiscal Year End                      December

Revenue (in US$ million)             38.13

Revenue (in EUR million)             28.60




SWOT Analysis                                                            Return on Equity

Strengths                            Weaknesses                          The company recorded a return on equity (ROE) of
                                                                         0.49% for 2010, as compared to its peers, Resilux NV
Broad Product Portfolio              Decline in Net Income               (Ticker: RES), Valsoia SpA (Ticker: VLS) and Loulis
                                                                         Mills S.A. (Ticker: KYLO), which recorded ROEs of
                                                                         17.76%, 16.69% and 4.97% respectively. The
Strong Focus towards Quality         Declining Current Assets            company reported a net profit margin of 7.15% in
                                                                         2010.
Strong Production and Distribution
Facilities
                                                                         Return on Equity
Opportunities                        Threats
                                     Customers’ Preference for Private
Business Expansion
                                     Labels

Recovering Economy                   Evolving Consumer Preferences

                                     Feedstock Price




                                                                         Liquidity Position

                                                                         The company reported a current ratio of 0.77 in 2010,
                                                                         as compared to its peers, Resilux NV, Valsoia SpA
                                                                         and Loulis Mills S.A., which recorded current ratios of
                                                                         1.29, 1.89 and 1.15 respectively. As of December
                                                                         2010, the company recorded cash and short-term
                                                                         investments of worth US$0.90 million, against
                                                                         US$5.16 million current debt. The company reported
                                                                         a debt to equity ratio of 1.58 in 2010 as compared to
                                                                         its peers, Resilux NV, Valsoia SpA and Loulis Mills
                                                                         S.A., which recorded debt to equity ratios of 0.59,
                                                                         0.03 and 0.46 respectively.




___________________________________________________________________________________________

Evrofarma S.A. - SWOT Profile                                                                                    Page 1
Evrofarma S.A.

_________________________________________________________________________________


TABLE OF CONTENTS

1     Business Analysis ................................................................................................................................... 5
    1.1       Company Overview ................................................................................................................................................5
    1.2       Business Description ..............................................................................................................................................5
    1.3       Major Products and Services .................................................................................................................................6
2     Analysis of Key Performance Indicators ............................................................................................... 7
    2.1       Five Year Snapshot: Overview of Financial and Operational Performance Indicators ..........................................7
    2.2       Key Financial Performance Indicators .................................................................................................................10
      2.2.1       Revenue and Operating Profit .........................................................................................................................10
      2.2.2       Asset, Liabilities and Capex .............................................................................................................................11
      2.2.3       Net Debt vs. Gearing Ratio ..............................................................................................................................12
      2.2.4       Operational Efficiency ......................................................................................................................................13
      2.2.5       Solvency ..........................................................................................................................................................14
      2.2.6       Valuation ..........................................................................................................................................................15
    2.3       Competitive Benchmarking ..................................................................................................................................16
      2.3.1       Market Capitalization .......................................................................................................................................17
      2.3.2       Efficiency ..........................................
								
To top